Profile data is unavailable for this security.
About the company
Avicanna Inc. is a commercial-stage international biopharmaceutical company. It focuses on the advancement and commercialization of cannabinoid-based products and formulations for the global medical and pharmaceutical market segments. Its products and services are grouped into four main categories, such as medical cannabis products; MyMedi.ca medical cannabis platform; pharmaceutical pipeline; and active pharmaceutical ingredients. The formulary of proprietary medical cannabis products is marketed under the RHO Phyto brand and offers a range of scientifically driven formulations in a variety of products, including oral, sublingual, topical, and transdermal deliveries with varying ratios of cannabinoids. MyMedi.ca offers a diverse portfolio of products and bilingual pharmacist-led patient support programs. It has developed a pipeline of proprietary, indication-specific cannabinoid-based candidates that are in various stages of clinical development. Trunerox is its oral formulation.
- Revenue in CAD (TTM)25.50m
- Net income in CAD-1.88m
- Incorporated2016
- Employees38.00
- LocationAvicanna Inc480 UNIVERSITY AVENUE, SUITE 1502TORONTO M5G 1V2CanadaCAN
- Phone+1 (647) 243-5283
- Fax+1 (647) 243-5283
- Websitehttps://avicanna.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Medicure Inc | 26.21m | -3.43m | 11.69m | 23.00 | -- | 0.6753 | -- | 0.446 | -0.3286 | -0.3286 | 2.51 | 1.66 | 0.9492 | 3.90 | 5.93 | 1,139,435.00 | -12.42 | -5.22 | -17.87 | -7.48 | 47.67 | 60.98 | -13.08 | -8.17 | 1.00 | -- | 0.0546 | -- | 0.9818 | 1.66 | -12.69 | -- | -44.35 | -- |
| Innovotech Inc | 4.46m | 383.40k | 13.61m | 16.00 | 26.18 | 4.73 | 27.80 | 3.05 | 0.0096 | 0.0096 | 0.0923 | 0.0529 | 1.85 | 19.32 | 7.96 | -- | 15.26 | 6.12 | 18.38 | 7.33 | 47.12 | 65.29 | 8.27 | 5.49 | 4.45 | -- | 0.00 | -- | 85.56 | 17.35 | 242.62 | -- | 141.95 | -- |
| Neurothera Labs Inc | 0.00 | -209.09k | 15.71m | -- | -- | 3.76 | -- | -- | -0.0116 | -0.0116 | 0.00 | 0.0493 | 0.00 | -- | -- | -- | -19.28 | -- | -21.28 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -143.95 | -- | -- | -- |
| Sirona Biochem Corp | -16.37k | -2.67m | 15.82m | -- | -- | -- | -- | -- | -0.0105 | -0.0105 | -0.00006 | -0.0134 | -0.0171 | -- | 1.61 | -- | -278.90 | -173.09 | -- | -383.49 | -- | -- | -- | -1,405.28 | -- | -5.73 | -- | -- | -94.82 | -51.37 | 28.52 | -- | -- | -- |
| Numinus Wellness Inc | 5.33m | -10.67m | 16.32m | 35.00 | -- | -- | -- | 3.06 | -0.0366 | -0.0481 | 0.0175 | -0.0049 | 0.5827 | -- | 3.41 | -- | -116.67 | -77.90 | -231.32 | -88.05 | 44.96 | 31.24 | -200.23 | -325.94 | -- | -- | 3.02 | -- | -82.02 | -- | 51.75 | -- | -- | -- |
| Hemostemix Inc | 0.00 | -3.40m | 17.57m | -- | -- | -- | -- | -- | -0.03 | -0.03 | 0.00 | -0.0188 | 0.00 | -- | -- | -- | -453.77 | -579.31 | -- | -- | -- | -- | -- | -- | -- | -6.01 | -- | -- | -- | -- | -4.57 | -- | -- | -- |
| Avicanna Inc | 25.50m | -1.88m | 21.37m | 38.00 | -- | 6.44 | -- | 0.838 | -0.0165 | -0.0165 | 0.2262 | 0.0264 | 1.22 | 2.89 | 10.84 | -- | -9.02 | -61.54 | -51.98 | -226.72 | 51.95 | 49.33 | -7.37 | -150.05 | 0.3804 | -- | 0.00 | -- | 51.62 | 172.88 | 58.62 | -- | -44.27 | -- |
| Resverlogix Corp | 0.00 | -9.66m | 27.33m | 18.00 | -- | -- | -- | -- | -0.034 | -0.034 | 0.00 | -0.4218 | 0.00 | -- | -- | 0.00 | -91.25 | -- | -- | -- | -- | -- | -- | -- | 0.0248 | -1.30 | -- | -- | -- | -- | 54.39 | -- | -- | -- |
| Thiogenesis Therapeutics Corp | 0.00 | -6.82m | 28.51m | -- | -- | 13.24 | -- | -- | -0.1439 | -0.1439 | 0.00 | 0.0415 | 0.00 | -- | -- | -- | -173.15 | -- | -216.52 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | 37.87 | -- | -- | -- |
| Principal Technologies Inc | 262.84k | -4.32m | 29.19m | -- | -- | -- | -- | 111.07 | -0.1043 | -0.1072 | 0.0063 | -0.0126 | 0.2272 | -- | 1.68 | -- | -372.16 | -- | -2,615.25 | -- | -- | -- | -1,637.81 | -- | -- | -223.78 | -- | -- | -44.22 | -- | -162.24 | -- | -- | -- |
| Microbix Biosystems Inc | 18.59m | -2.25m | 30.48m | 69.00 | -- | 1.10 | -- | 1.64 | -0.0161 | -0.0161 | 0.1344 | 0.1992 | 0.4923 | 1.12 | 6.44 | -- | -5.95 | 3.86 | -6.48 | 4.37 | 53.02 | 55.92 | -12.08 | 6.37 | 5.17 | -2.23 | 0.196 | -- | -26.81 | 12.04 | -163.80 | -- | -0.4115 | -- |
